These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 20952751)

  • 1. Psychoneuroendocrine modulation of regulatory T lymphocyte system: in vivo and in vitro effects of the pineal immunomodulating hormone melatonin.
    Vigoré L; Messina G; Brivio F; Fumagalli L; Rovelli F; DI Fede G; Lissoni P
    In Vivo; 2010; 24(5):787-9. PubMed ID: 20952751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroimmunomodulation in medical oncology: application of psychoneuroimmunology with subcutaneous low-dose IL-2 and the pineal hormone melatonin in patients with untreatable metastatic solid tumors.
    Lissoni P; Brivio F; Fumagalli L; Messina G; Vigoré L; Parolini D; Colciago M; Rovelli F
    Anticancer Res; 2008; 28(2B):1377-81. PubMed ID: 18505083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticancer neuroimmunomodulation by pineal hormones other than melatonin: preliminary phase II study of the pineal indole 5-methoxytryptophol in association with low-dose IL-2 and melatonin.
    Lissoni P; Fumagalli L; Paolorossi F; Rovelli F; Roselli MG; Maestroni GJ
    J Biol Regul Homeost Agents; 1997; 11(3):119-22. PubMed ID: 9498162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations of pineal gland and of T lymphocyte subsets in metastatic cancer patients: preliminary results.
    Lissoni P; Tancini G; Barni S; Viviani S; Archili C; Cattaneo G; Fiorelli G
    J Biol Regul Homeost Agents; 1989; 3(4):181-3. PubMed ID: 2534688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between psychoncology and psychoneuroendocrinoimmunology (PNEI): enhanced T-regulatory lymphocyte activity in cancer patients with self-punishement, evaluated by Rorschach test.
    Messina G; Lissoni P; Bartolacelli E; Magotti L; Clerici M; Marchiori P; Colombo E
    In Vivo; 2010; 24(1):75-8. PubMed ID: 20133980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is there a role for melatonin in supportive care?
    Lissoni P
    Support Care Cancer; 2002 Mar; 10(2):110-6. PubMed ID: 11862501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase II study of neuroimmunotherapy with subcutaneous low-dose IL-2 plus the pineal hormone melatonin in untreatable advanced hematologic malignancies.
    Lissoni P; Bolis S; Brivio F; Fumagalli L
    Anticancer Res; 2000; 20(3B):2103-5. PubMed ID: 10928160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total pineal endocrine substitution therapy (TPEST) as a new neuroendocrine palliative treatment of untreatable metastatic solid tumor patients: a phase II study.
    Lissoni P; Malugani F; Brivio F; Piazza A; Vintimilla C; Giani L; Tancini G
    Neuro Endocrinol Lett; 2003; 24(3-4):259-62. PubMed ID: 14523367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemotherapy with immunomodulating pineal hormones other than melatonin: 5-methoxytryptamine as a new oncostatic pineal agent.
    Lissoni P
    Pathol Biol (Paris); 2007; 55(3-4):198-200. PubMed ID: 17451889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunomodulatory properties of a pineal indole hormone other than melatonin, the 5-methoxytryptophol.
    Lissoni P; Pittalis S; Rovelli F; Zecchini S; Casati M; Tremolada M; Pelizzoni F
    J Biol Regul Homeost Agents; 1996; 10(1):27-30. PubMed ID: 9049779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroimmunotherapy of untreatable metastatic solid tumors with subcutaneous low-dose interleukin-2, melatonin and naltrexone: modulation of interleukin-2-induced antitumor immunity by blocking the opioid system.
    Lissoni P; Malugani F; Malysheva O; Kozlov V; Laudon M; Conti A; Maestroni G
    Neuro Endocrinol Lett; 2002 Aug; 23(4):341-4. PubMed ID: 12195238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the pineal gland in the control of macrophage functions and its possible implication in cancer: a study of interactions between tumor necrosis factor-alpha and the pineal hormone melatonin.
    Lissoni P; Barni S; Tancini G; Brivio F; Tisi E; Zubelewicz B; Braczkowski R
    J Biol Regul Homeost Agents; 1994; 8(4):126-9. PubMed ID: 7660855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary study on modulation of the biological effects of tumor necrosis factor-alpha in advanced cancer patients by the pineal hormone melatonin.
    Brackowski R; Zubelewicz B; Romanowski W; Lissoni P; Barni S; Tancini G; Maestroni GJ
    J Biol Regul Homeost Agents; 1994; 8(3):77-80. PubMed ID: 7754792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melatonin as biological response modifier in cancer patients.
    Neri B; de Leonardis V; Gemelli MT; di Loro F; Mottola A; Ponchietti R; Raugei A; Cini G
    Anticancer Res; 1998; 18(2B):1329-32. PubMed ID: 9615811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-helper/T-regulator lymphocyte ratio as a new immunobiological index to quantify the anticancer immune status in cancer patients.
    Brivio F; Fumagalli L; Parolini D; Messina G; Rovelli F; Rescaldani R; Vigore L; Vezzo R; Vaghi M; Di Bella S; Lissoni P
    In Vivo; 2008; 22(5):647-50. PubMed ID: 18853761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-2, melatonin and interleukin-12 as a possible neuroimmune combination in the biotherapy of cancer.
    Lissoni P; Pittalis S; Rovelli F; Vigorè L; Roselli MG; Brivio F
    J Biol Regul Homeost Agents; 1995; 9(2):63-6. PubMed ID: 9127635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological effects of a single evening subcutaneous injection of low-dose interleukin-2 in association with the pineal hormone melatonin in advanced cancer patients.
    Lissoni P; Barni S; Ardizzoia A; Brivio F; Tancini G; Conti A; Maestroni GJ
    J Biol Regul Homeost Agents; 1992; 6(4):132-6. PubMed ID: 1296454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synchronization of cortisol circadian rhythm by the pineal hormone melatonin in untreatable metastatic solid tumor patients and its possible prognostic significance on tumor progression.
    Brivio F; Fumagalli L; Fumagalli G; Pescia S; Brivio R; Di Fede G; Rovelli F; Lissoni P
    In Vivo; 2010; 24(2):239-41. PubMed ID: 20364003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melatonin as a new possible anti-inflammatory agent.
    Lissoni P; Rovelli F; Meregalli S; Fumagalli L; Musco F; Brivio F; Brivio O; Esposti G
    J Biol Regul Homeost Agents; 1997; 11(4):157-9. PubMed ID: 9582617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The immune-pineal axis: a shuttle between endocrine and paracrine melatonin sources.
    Markus RP; Ferreira ZS; Fernandes PA; Cecon E
    Neuroimmunomodulation; 2007; 14(3-4):126-33. PubMed ID: 18073503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.